Skip to main content
Learn More
Learn More
Learn More
Learn More

Posted by Newsbytes

Newsbytes

How Theranos’ faulty blood tests got to market – and what that shows about gaps in FDA regulation || Ana Santos Rutschman :: The Conversation

Posted by Newsbytes • Profile • 10/05/21 at 10:11AM • Government • Health - Wellness - Nutrition - Aging • Public Interest • See more by Newsbytes

One of the most high-profile trials of the year is underway to decide whether Theranos founder Elizabeth Holmes defrauded patients and investors. Read more

Author, Ana Santos Rutschman Assistant Professor of Law, Saint Louis University

Login to Comment Profile
See More by Newsbytes View Public Posts View Local Posts